Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individuals.
Müller
C I
CI
Luong
Q T
QT
Shih
L-Y
LY
Jones
L C
LC
Desmond
J C
JC
Kawamata
N
N
Tcherniantchouk
O
O
Liu
Q
Q
Ito
K
K
Osato
M
M
Ito
Y
Y
Tefferi
A
A
de Vos
S
S
Koeffler
H P
HP
D014408:Biomarkers, Tumor / Q000235:genetics; D002453:Cell Cycle / Q000235:genetics; D050677:Core Binding Factor Alpha 3 Subunit / Q000235:genetics*; D003937:Diagnosis, Differential; D020869:Gene Expression Profiling; D052138:Genes, Neoplasm; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D009196:Myeloproliferative Disorders / Q000145:classification / Q000175:diagnosis* / Q000235:genetics; D016212:Transforming Growth Factor beta / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D014408:Biomarkers, Tumor; D050677:Core Binding Factor Alpha 3 Subunit; C493729:Runx3 protein, human; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; C507924:JAK2 protein, human; D053614:Janus Kinase 2